Huadong Medicine’s Patent Challenge Against Novo Nordisk’s Ozempic Heads to Hearing
February 23 will mark the oral hearing phase for the patent challenge case brought by...
Peg-Bio Biopharma
Huadong Medicine’s Biosimilar Ozempic (Semaglutide) Wins NMPA Clinical Trial Approval
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that a clinical trial filing for its...